Overview
Meghan Milburn is a Surgical Oncologist and a General Surgeon in Annapolis, Maryland. Dr. Milburn is highly rated in 7 conditions, according to our data. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Milburn is currently accepting new patients.
Her clinical research consists of co-authoring 2 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
Locations
2000 Medical Pkwy, Suite 200, Annapolis, MD 21401
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
David Euhus is a Surgical Oncologist and a General Surgeon in Baltimore, Maryland. Dr. Euhus is highly rated in 9 conditions, according to our data. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Mastectomy, and Lymphadenectomy.
Skip Viragh Outpatient Cancer Center
Richard Burkhart, M.D., is an Associate Professor of Surgery at The Johns Hopkins Hospital with a focus on complex minimally-invasive surgery and research for cancers of the pancreas, liver and bile ducts. Dr. Burkhart received his medical degree from Boston University and completed his surgical residency and research fellowships at the Thomas Jefferson University Hospital in Philadelphia and the Cold Spring Harbor Laboratories. He is a member of several professional organizations, including the American Association of Cancer Research, the American College of Surgeons, the Society of Surgery for the Alimentary Tract, the Pancreas Club, and the Society of Surgical Oncology. Outside the operating room, Dr. Burkhart heads a multidisciplinary laboratory team dedicated to bringing next-generation precision medicine approaches into the routine clinical care of patients that we serve. He has a particular research interest in using personalized models of pancreas cancer, made from tumor during and immediately after surgical resection, to select the best chemotherapy for each patient to support long-term survival and improve rates of disease cure. The laboratory team, funded in part by the National Institutes of Health, the National Cancer Institute, the Lustgarten Foundation and Stand Up to Cancer, is also thankful to the many patients who have supported the work through philanthropic gift. Dr. Burkhart is highly rated in 15 conditions, according to our data. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy.
Johns Hopkins Outpatient Center
Jin He, M.D., Ph.D., is a professor of surgery at the Johns Hopkins University School of Medicine and is the Division Chief of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology. Dr. He specializes in diseases and tumors of the pancreas, liver, bile duct, and gallbladder. He performs open as well as minimally invasive (robotic and laparoscopic) surgery, including the Whipple procedure. Dr. He received his medical degree from Beijing Medical University and a Ph.D. in oncology from Fudan University Shanghai Medical College. He completed the Halsted general surgery residency training at Johns Hopkins, followed by an ACGME accredited fellowship in complex general surgical oncology at Johns Hopkins. Dr. He is the John Cameron Professor of Alimentary Tract Diseases. Dr. He’s research focuses on personalized treatment through stratifying pancreatic tumors on their genetic features. He holds several patents in anti-cancer vascular targeting agents and has published extensively in peer-reviewed journals and lectured internationally. He serves on several national committees, including the NCCN panel on neuroendocrine tumors and the Alliance for Clinical Trials in Oncology. Dr. He is highly rated in 24 conditions, according to our data. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Pancreaticoduodenectomy.
Frequently Asked Questions about Dr. Meghan L. Milburn
How do I make an appointment with Dr. Meghan L. Milburn?
You can book an appointment with Dr. Meghan L. Milburn by calling their office at 443-481-5300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Meghan L. Milburn a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Meghan L. Milburn is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Meghan L. Milburn specialize in?
While Dr. Meghan L. Milburn is a Surgical Oncology, they have specific expertise in Breast Cancer, Paget Disease of the Breast, and Inflammatory Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Surgical Oncology.
Does Dr. Meghan L. Milburn participate in research or clinical trials?
Yes. Dr. Meghan L. Milburn has published 2 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Meghan L. Milburn's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Meghan L. Milburn accept my insurance?
Dr. Meghan L. Milburn accepts most major insurance plans, including Anthem BCBS and CareFirst. We recommend calling the office directly at 443-481-5300 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Milburn isDistinguished. Learn about Breast Cancer.
- Inflammatory Breast CancerDr. Milburn isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Milburn isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- AngiosarcomaDr. Milburn isAdvanced. Learn about Angiosarcoma.
- Breast LumpDr. Milburn isAdvanced. Learn about Breast Lump.
- Intraductal PapillomaDr. Milburn isAdvanced. Learn about Intraductal Papilloma.
- LymphedemaDr. Milburn isAdvanced. Learn about Lymphedema.
- Experienced
- BRCA Positive Breast CancerDr. Milburn isExperienced. Learn about BRCA Positive Breast Cancer.
- Breast InfectionDr. Milburn isExperienced. Learn about Breast Infection.
- FibroadenomaDr. Milburn isExperienced. Learn about Fibroadenoma.
- Fibrocystic Breast DiseaseDr. Milburn isExperienced. Learn about Fibrocystic Breast Disease.
- GalactocoeleDr. Milburn isExperienced. Learn about Galactocoele.
- Giant Mammary HamartomaDr. Milburn isExperienced. Learn about Giant Mammary Hamartoma.

